The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
50 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $14,173,374 in first-year total cost, median $310,542.
Most frequent study sections
- Chronic Dysfunction and Integrative Neurodegeneration Study Section[CDIN]6
- Cellular and Molecular Biology of Neurodegeneration Study Section[CMND]4
- Aging, Injury, Musculoskeletal, and Rheumatologic Disorders Study Section[AIMR]3
- Cognitive Disorders and Brain Aging Study Section[CDBA]3
- Neural Oxidative Metabolism and Death Study Section[NOMD]3
Most frequent institutions
- UNIVERSITY OF ARIZONA3
- BROWN UNIVERSITY2
- EMORY UNIVERSITY2
- MASSACHUSETTS GENERAL HOSPITAL2
- NORTHWESTERN UNIVERSITY2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Targeting the astrocyte-cerebrovasculature system to correct brain bioenergetics defects associated with APOE41R03AG087463-01A1 | NKILIZA, AURORE | ROSKAMP INSTITUTE, INC., FL | $341,000 | NOMD |
| 2025 | Pen-and-Paper and Smartphone Self-Reported Cognitive Concerns to Predict Longitudinal Alzheimer's Biomarkers in a Diverse, Non-Demented Older Adult Population1R03AG095655-01 | GARCIA DE LA GARZA, ANGEL | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $336,000 | CDBA |
| 2025 | Alzheimer's Disease Organelle Proteome Task (ADOPT)-pilot phase1R03AG091095-01 | WANG, BIAO | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $328,000 | EBIT |
| 2025 | Exploring heterogeneity of cognitive trajectories of preclinical Alzheimer's disease with digital phenotyping1R03AG095992-01 | DING, HUITONG | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $327,000 | CDBA |
| 2025 | Blood plasma metrics as disease biomarkers in atypical Alzheimer's disease1R03AG091264-01 | SINGH-REILLY, NEHA | MAYO CLINIC ROCHESTER, MN | $320,143 | CNN |
| 2025 | Study to Understand Participant Perspectives On Respite upTake (SUPPORT)1R03AG093098-01 | O'CONOR, RACHEL | NORTHWESTERN UNIVERSITY, IL | $320,000 | CMGC |
| 2025 | The role of chronic migraine as an early biomarker of Alzheimer's Disease1R03AG090954-01A1 | FISCHER, KATHRYN | INDIANA UNIVERSITY INDIANAPOLIS, IN | $317,000 | ZRG1 |
| 2025 | Enhancing Synaptic Autophagy for Neuroprotection in Alzheimer's disease1R03AG091250-01 | GROSSO JASUTKAR, HILARY | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $314,000 | CMND |
| 2025 | Molecular mechanisms underlying reduced vitamin C transport process in Alzheimer's disease and its impact on neuroinflammation1R03AG087936-01A1 | SUBRAMANIAN, VEEDAMALI S | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $314,000 | CDIN |
| 2025 | Functional Analysis of Late-onset Alzheimer’s Disease-Associated Genes in Neurodegeneration and Protein Aggregation-induced Neurotoxicity1R03AG087390-01A1 | E, LEZI | MEDICAL COLLEGE OF WISCONSIN, WI | $312,000 | CMND |
| 2025 | Integrating spatial transcriptomics and single cell RNA-sequencing to mechanistically define bariatric surgery's impact on Alzheimer's Disease1R03AG088813-01A1 | HARRIS, DAVID A | UNIVERSITY OF WISCONSIN-MADISON, WI | $311,000 | ZRG1 |
| 2025 | TMEM106B and Mitochondrial Dysfunction in FTLD and Other Dementia1R03AG094840-01 | GAO, JU | UNIVERSITY OF ARIZONA, AZ | $310,083 | NOMD |
| 2025 | Mitochondrial liquid-liquid phase separation in Alzheimer's disease1R03AG087431-01A1 | KIM, NAM CHUL | UNIVERSITY OF MINNESOTA, MN | $308,000 | MSFB |
| 2025 | Leveraging large datasets to determine genomic impact of transposable elements in Alzheimer’s Disease and related dementias1R03AG087485-01A1 | ZHOU, WEICHEN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $303,449 | GVE |
| 2025 | Innovative Data Integration Models for Handling Evidence Inconsistency in AD/ADRD Research1R03AG093555-01 | LIN, LIFENG | UNIVERSITY OF ARIZONA, AZ | $301,417 | ASPA |
| 2025 | Microvascular endothelial lipid metabolism as a target for age-related vascular cognitive impairment1R03AG095868-01 | BALASUBRAMANIAN, PRIYA | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $286,000 | BINP |
| 2025 | The role of depolarizing GABA in Alzheimer's disease1R03AG092302-01 | MARTINA, MARCO | NORTHWESTERN UNIVERSITY, IL | $160,000 | CDIN |
| 2025 | Mapping Structural Brain Networks Linked to Mild Behavioral Impairment1R03AG095395-01 | IORDAN, ALEXANDRU DANIEL | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $156,000 | CDBA |
| 2025 | A culturally grounded approach to understanding and improving Alzheimer'sdisease and related dementia (ADRD) knowledge, attitudes, and behaviors forAmerican Samoan family caregivers1R03AG087409-01A1 | EAKINS, DANIELLE | AMERICAN SAMOA COMMUNITY CANCER COALITIO, AS | $143,693 | SPIP |
| 2024 | Early detection & monitoring of memory decline in a representative sample of older adults at risk for Alzheimer's disease and related dementias1R03AG089320-01 | PAPP, KATHRYN VICTORIA | BRIGHAM AND WOMEN'S HOSPITAL, MA | $353,391 | APDA |
| 2024 | Contribution of Mitochondrial Associated Membrane (MAM) Signaling to Neurodegeneration1R03AG087416-01 | KATZ, SAMUEL G | YALE UNIVERSITY, CT | $335,000 | NOMD |
| 2024 | Metabolic signatures of the MIND diet to objectively investigate with all cause and Alzheimer’s Disease dementia and PET imaging Biomarkers of Alzheimer's Disease1R03AG087437-01 | MELO VAN LENT, DEBORA | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $334,297 | AIMR |
| 2024 | Next generation metabolic imaging of the effect of exercise on mitochondrial function in Alzheimer's disease1R03AG087483-01 | YEN, YI-FEN | MASSACHUSETTS GENERAL HOSPITAL, MA | $332,096 | ZRG1 |
| 2024 | Place, Stress and Cognitive Status Among Black Men during middle and late life1R03AG089289-01 | BRUCE, MARINO A | UNIVERSITY OF HOUSTON, TX | $331,270 | NMBH |
| 2024 | Time-Dynamic Tree-Based Methods for Personalized Alzheimer's Disease Prediction1R03AG083470-01A1 | ZHU, YUXIN | JOHNS HOPKINS UNIVERSITY, MD | $327,500 | ASPA |
| 2024 | Proteomic markers of risk for cognitive impairment in people with type 2 diabetes1R03AG088803-01 | SHAPIRO, ALLISON LIVIA BUTI | UNIVERSITY OF COLORADO DENVER, CO | $326,797 | ASG |
| 2024 | Development of new tools to explore the role of oligodendrocyte-derived carnosine in Alzheimer Disease1R03AG087284-01 | ELBAZ-EILON, BENAYAHU | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $320,000 | CMBG |
| 2024 | Tau-RNA crosstalk: Alternative Poly-Adenylation (APA) Regulation in Alzheimer's Disease1R03AG088929-01 | MONTALBANO, MAURO | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $320,000 | CMND |
| 2024 | Defining rates of cognitive aging in adults with and without dementia using the CODA cohort1R03AG088764-01 | KUNICKI, ZACHARY | BROWN UNIVERSITY, RI | $319,000 | AIMR |
| 2024 | Rural-urban and within-rural disparities in Alzheimer's disease and Alzheimer’s disease-related dementias1R03AG085059-01A1 | ZACHER, MEGHAN | BROWN UNIVERSITY, RI | $319,000 | SSPA |
| 2024 | The Impact of Hospice Care on the Wellbeing of Alzheimer's Disease Patients and Their Family Members1R03AG088983-01 | JI, YUNAN | NATIONAL BUREAU OF ECONOMIC RESEARCH, MA | $318,416 | ODHS |
| 2024 | Investigating Mechanisms of Complement Mediated Synaptic Removal1R03AG083563-01A1 | BENSKEY, MATTHEW JOHN | HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES, MI | $314,000 | NC |
| 2024 | Targeting p38/MK2 protein-protein interaction to control neuroinflammation in Alzheimer's Disease1R03AG087482-01 | IVANOV, ANDREY | EMORY UNIVERSITY, GA | $313,000 | MSFB |
| 2024 | Assessment of the therapeutic potential of the anticancer agent Silmitasertib in the treatment of memory loss in Frontotemporal dementia1R03AG087281-01 | GOMEZ-PASTOR, ROCIO | UNIVERSITY OF MINNESOTA, MN | $310,000 | CDIN |
| 2024 | Cell Type-Specific Alternative polyadenylation of mRNA in Alzheimer's disease1R03AG087283-01A1 | GROZDANOV, PETAR | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX | $310,000 | MNG |
| 2024 | Disruption of sensory pathways in dementia pathogenesis1R03AG087423-01 | CRISH, CHRISTINE MARIE | NORTHEAST OHIO MEDICAL UNIVERSITY, OH | $309,960 | CDIN |
| 2024 | Targeting Excitability in Alzheimer's Disease1R03AG087436-01 | WONG, JENNIFER C. | EMORY UNIVERSITY, GA | $307,230 | CNNT |
| 2024 | Effects of early Alzheimer's pathogenesis on memory accuracy and precision1R03AG087366-01A1 | HILL, PAUL | UNIVERSITY OF ARIZONA, AZ | $307,000 | ZRG1 |
| 2024 | Quantifying myelin degeneration in AD1R03AG083702-01A1 | GEORGIADIS, MARIOS | STANFORD UNIVERSITY, CA | $305,014 | EITN |
| 2024 | Striatal Contribution to the Motor Symptoms and Aphasia in GRN-FTD1R03AG087418-01A1 | LI, YUQING | UNIVERSITY OF FLORIDA, FL | $305,000 | CDIN |
| 2024 | Precision blood pressure control, cognition and adverse events in older adults: detecting heterogeneity in treatment effects in randomized trialsusing machine-learning approaches1R03AG087481-01A1 | MA, YUAN | HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH, MA | $302,960 | AIMR |
| 2024 | Tracking Autocorrection to Explain its Sensitivity to AD1R03AG087411-01 | LI, CHUCHU | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $294,484 | APDA |
| 2024 | Temporal Dynamics and Associations of Device-based Activity Distribution Metrics and Everyday Cognition in Older Adults1R03AG087445-01 | YANG, CHIH-HSIANG | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $287,416 | LCBH |
| 2024 | Pathogenic Role of APP E590D in Alzheimer’s Disease.1R03AG084948-01A1 | LIU, TIAN | CASE WESTERN RESERVE UNIVERSITY, OH | $161,000 | CMND |
| 2024 | The role of microtubule network in a mouse model of Alzheimer’s disease1R03AG085121-01A1 | ALARCON, JUAN MARCOSSHUMYATSKY, GLEB P | RUTGERS, THE STATE UNIV OF N.J., NJ | $157,000 | CDIN |
| 2024 | Potential miRNA biomarkers and miRNA regulatory targets underlying early congnitive impairement and progression to Alzhiemer's disease1R03AG088906-01 | KARERE, GENESIO | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $155,000 | ZRG1 |
| 2024 | A novel physical activity metric predicts cognitive and brain aging and ADRD risk1R03AG088612-01 | CAI, YURUN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $154,858 | ZRG1 |
| 2024 | Alzheimer's Disease (AD) and Vascular Brain Injury- related changes in longitudinal Magnetic Resonance Imaging associated with Intraindividual Cognitive Variability in Aging American Indians.1R03AG081892-01A1 | FONSECA, LUCIANA | WASHINGTON STATE UNIVERSITY, WA | $152,400 | CNN |
| 2024 | Development of Biotherapeutic Nanogels for Alzheimers Disease Treatment1R03AG087475-01 | VASHIST, ARTI | FLORIDA INTERNATIONAL UNIVERSITY, FL | $147,500 | ZRG1 |
| 2024 | A Pilot Study of Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients (SLEEP-BOOST)1R03AG087439-01 | GAO, LEI | MASSACHUSETTS GENERAL HOSPITAL, MA | $134,000 | ASG |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.